Corvus Pharmaceuticals, Inc.
CRVS
3 insider filings · Latest: May 18, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| May 18, 2026 | May 20 8:12 PM | Richard A Miller MDDirector, President and CEO | Purchase | 6,932 | $12.04 | $83.5K | 1,195,035(I) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Apr 23, 2026 | Apr 27 9:32 PM | Andrew C. ChanDirector | Grant/Award | 30,000 | $16.02 | 30,000(D) | View → |
| Jan 28, 2026 | Jan 30 11:39 PM | Peter A. ThompsonDirector, 10% Owner | Option Exercise | 210,000 | $15.00 | 0(D) | View → |